Healthcare News

WHO Looks To Cut ‘Overly Expensive’ Insulin Price, Make More Generic Versions

Written by David Miller

The World Health Organization (WHO) has launched a new initiative that aims to encourage companies to reduce the price of insulin or to produce new generic versions.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

[mwai_chat window="true" fullscreen="true"]